WeVote

Bill

Bill

A 5325

Requires health insurance coverage for certain neurological diseases.

2024-2025 Regular Session Introduced by Margie Donlon and 5 co-sponsors

New Jersey bill requires health insurers to cover specified neurological disease treatments, expanding access but potentially increasing insurance costs for all policyholders.

Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
0
WeVote Research Nonpartisan
Bill Summary · A 5325

Legislative bill overview

Assembly Bill A 5325 mandates that health insurance plans in New Jersey cover treatment for specified neurological diseases. The bill was introduced in February 2025 and is currently under review by the Assembly's Financial Institutions and Insurance Committee. The legislation aims to ensure broader access to care for individuals diagnosed with these conditions.

Why is this important

Neurological diseases often require expensive, specialized treatments that may not be covered under standard insurance plans, creating financial barriers to care. This mandate could significantly improve access to treatment for New Jersey residents while potentially increasing healthcare costs for insurers and premium holders. The outcome will affect insurance market dynamics, patient outcomes, and healthcare spending in the state.

Potential points of contention

  • Coverage scope and cost: The bill's specific diseases and treatment types are not detailed in available information; broader coverage typically increases premiums for all policyholders
  • Insurer burden: Insurance companies may argue the mandate reduces flexibility and increases operational costs, potentially leading to higher premiums or reduced plan options
  • Definition and criteria: Ambiguity around which neurological diseases qualify could create disputes between patients, providers, and insurers over coverage eligibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.